Apyx Net Working Capital from 2010 to 2025

APYX Stock  USD 1.34  0.04  2.90%   
Apyx Medical Net Working Capital yearly trend continues to be fairly stable with very little volatility. Net Working Capital will likely drop to about 40.2 M in 2025. During the period from 2010 to 2025, Apyx Medical Net Working Capital regression line of annual values had r-squared of  0.39 and arithmetic mean of  34,870,888. View All Fundamentals
 
Net Working Capital  
First Reported
2020-03-31
Previous Quarter
42.6 M
Current Value
45.7 M
Quarterly Volatility
9.6 M
 
Covid
Check Apyx Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Apyx Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 733.6 K, Interest Expense of 6.2 M or Selling General Administrative of 45.3 M, as well as many indicators such as Price To Sales Ratio of 1.11, Dividend Yield of 0.0 or PTB Ratio of 3.75. Apyx financial statements analysis is a perfect complement when working with Apyx Medical Valuation or Volatility modules.
  
Check out the analysis of Apyx Medical Correlation against competitors.
For more information on how to buy Apyx Stock please use our How to Invest in Apyx Medical guide.

Latest Apyx Medical's Net Working Capital Growth Pattern

Below is the plot of the Net Working Capital of Apyx Medical over the last few years. It is Apyx Medical's Net Working Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Apyx Medical's overall financial position and show how it may be relating to other accounts over time.
Net Working Capital10 Years Trend
Slightly volatile
   Net Working Capital   
       Timeline  

Apyx Net Working Capital Regression Statistics

Arithmetic Mean34,870,888
Geometric Mean29,121,243
Coefficient Of Variation62.30
Mean Deviation18,765,498
Median31,122,000
Standard Deviation21,725,367
Sample Variance472T
Range65.2M
R-Value0.63
Mean Square Error307.5T
R-Squared0.39
Significance0.01
Slope2,856,837
Total Sum of Squares7079.9T

Apyx Net Working Capital History

202540.2 M
202445.7 M
202357.6 M
202231.1 M
202147.5 M
202056.9 M
201964.4 M

About Apyx Medical Financial Statements

Apyx Medical investors use historical fundamental indicators, such as Apyx Medical's Net Working Capital, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Apyx Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Working Capital45.7 M40.2 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Apyx Stock Analysis

When running Apyx Medical's price analysis, check to measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.